Although the aforementioned four flavonoids could induce the expression of erythropoietin in cultured kidney cells and stimulate the estrogenic activity in cultured mammalian breast cancer cells, the induction magnitude of aglycones is better than their corresponding glycosides [12, 13]. This evidence concerns the gene EPO and breast carcinoma.